trending Market Intelligence /marketintelligence/en/news-insights/trending/epdpcfjudtlekpwby_sirg2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Kubota Pharmaceutical to form ophthalmology joint venture with SBI Holdings

Street Talk Episode 41 - How to Win the Funding Battle, Use Fintech to Play Offense

Forward Spark Spreads Suggest Rising Profitability Of US Renewables As Sector Matures

MA Activity The Big Story In Mature Online Video Platform Market

Martina Cheung Backs The Quality Program


Kubota Pharmaceutical to form ophthalmology joint venture with SBI Holdings

Kubota Pharmaceutical Holdings Co. Ltd. plans to form a joint venture with SBI Holdings Inc. to invest in ophthalmic drugs and devices.

The entity will be 51% funded by Kubota Pharma and 49% by SBI Holdings and is likely to first invest in mobile healthcare applications in the field of ophthalmology.

Kubota Pharmaceutical is the parent of Acucela Inc.